Decoding m6Am by simultaneous transcription-start mapping and methylation quantification
N 6 ,2’- O -dimethyladenosine (m 6 Am) is a modified nucleotide located at the first transcribed position in mRNA and snRNA that is essential for diverse physiological processes. m 6 Am mapping methods assume each gene uses a single start nucleotide. However, gene transcription usually involves multiple start sites, generating numerous 5’ isoforms. Thus, gene-level annotations cannot capture the diversity of m 6 Am modification in the transcriptome. Here, we describe CROWN-seq, which simultaneously identifies transcription-start nucleotides and quantifies m 6 Am stoichiometry for each 5’ isoform that initiates with adenosine. Using CROWN-seq, we map the m 6 Am landscape in nine human cell lines. Our findings reveal that m 6 Am is nearly always a high stoichiometry modification, with only a small subset of cellular mRNAs showing lower m 6 Am stoichiometry. We find that m 6 Am is associated with increased transcript expression and provide evidence that m 6 Am may be linked to transcription initiation associated with specific promoter sequences and initiation mechanisms. These data suggest a potential new function for m 6 Am in influencing transcription.
Authors
- Samie R. Jaffrey (ORCID: https://orcid.org/0000-0003-3615-6958)
- Ben R Hawley (ORCID: https://orcid.org/0000-0002-2458-7868)
- Jianheng Liu (ORCID: https://orcid.org/0000-0003-0216-1951)
- L. V. B. Nicholson (ORCID: https://orcid.org/0009-0005-8203-7249)
Institutions
- Cornell University (US)
Publication Details
- Journal
- eLife
- Published
- 2025-03-31
- DOI
- https://doi.org/10.7554/elife.104139.3
- Citations
- 2
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- National Institute of Mental Health
- National Institute on Drug Abuse
- National Human Genome Research Institute
- NIH Office of the Director
- National Institute of Neurological Disorders and Stroke